×
About 678 results

ALLMedicine™ Bullous Diseases Center

Research & Reviews  335 results

Autoantibodies to desmocollin 3 in pemphigus exclusively recognize calcium-dependent ep...
https://doi.org/10.1016/j.jid.2021.01.032
The Journal of Investigative Dermatology; Koga H, Teye K et. al.

Mar 26th, 2021 - Pemphigus is a group of autoimmune bullous diseases characterized by the presence of autoantibodies against adhesion molecules, desmogleins (Dsg) and desmocollins (Dsc). Pathogenicity of anti-Dsc3 antibodies in pemphigus has been demonstrated, how...

The pathogenic role of CD4+ tissue-resident memory T cells bearing Tfh-like phenotype i...
https://doi.org/10.1016/j.jid.2021.01.030
The Journal of Investigative Dermatology; Zou Y, Yuan H et. al.

Mar 20th, 2021 - In the skin lesions of pemphigus, a group of life-threatening autoimmune bullous diseases, an overrepresentation of CD4+ tissue-resident memory T (TRM) cells was found. We sought to investigate the contributions of CD4+ TRM cells to the severity a...

A retrospective cohort study of hepatitis B reactivation in patients with autoimmune bu...
https://doi.org/10.1016/j.jaad.2020.12.085
Journal of the American Academy of Dermatology; Li TF, Tang-Lin L et. al.

Jan 18th, 2021 - A retrospective cohort study of hepatitis B reactivation in patients with autoimmune bullous diseases on immunosuppressive therapy in Singapore.|2021|Li TF,Tang-Lin L,Ang CC,|

Incidence of pemphigoid diseases in Northern Germany in 2016 - first data from the Schl...
https://doi.org/10.1111/jdv.17107
Journal of the European Academy of Dermatology and Venere... van Beek N, Weidinger A et. al.

Jan 11th, 2021 - Autoimmune bullous diseases (AIBD) are rare disorders characterized by autoantibody formation against components of adhesion molecules; in pemphigoid diseases (PD), these are proteins of hemidesmosomes and basement membrane, important for cell-mat...

Characteristics and outcomes of COVID-19 in patients with autoimmune bullous diseases: ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836213
Journal of the American Academy of Dermatology; Mahmoudi H, Farid AS et. al.

Dec 28th, 2020 - Characteristics and outcomes of COVID-19 in patients with autoimmune bullous diseases: A retrospective cohort study.|2020|Mahmoudi H,Farid AS,Nili A,Dayani D,Tavakolpour S,|

see more →

Guidelines  1 results

Pemphigus. S2 Guideline for diagnosis and treatment--guided by the European Dermatology...
https://doi.org/10.1111/jdv.12772
Journal of the European Academy of Dermatology and Venere... Hertl M, Jedlickova H et. al.

Oct 23rd, 2014 - Pemphigus encompasses a group of life-threatening autoimmune bullous diseases characterized by blisters and erosions of the mucous membranes and skin. Before the era of immunosuppressive treatment, the prognosis of pemphigus was almost fatal. Due ...

see more →

Clinicaltrials.gov  339 results

Autoantibodies to desmocollin 3 in pemphigus exclusively recognize calcium-dependent ep...
https://doi.org/10.1016/j.jid.2021.01.032
The Journal of Investigative Dermatology; Koga H, Teye K et. al.

Mar 26th, 2021 - Pemphigus is a group of autoimmune bullous diseases characterized by the presence of autoantibodies against adhesion molecules, desmogleins (Dsg) and desmocollins (Dsc). Pathogenicity of anti-Dsc3 antibodies in pemphigus has been demonstrated, how...

The pathogenic role of CD4+ tissue-resident memory T cells bearing Tfh-like phenotype i...
https://doi.org/10.1016/j.jid.2021.01.030
The Journal of Investigative Dermatology; Zou Y, Yuan H et. al.

Mar 20th, 2021 - In the skin lesions of pemphigus, a group of life-threatening autoimmune bullous diseases, an overrepresentation of CD4+ tissue-resident memory T (TRM) cells was found. We sought to investigate the contributions of CD4+ TRM cells to the severity a...

A retrospective cohort study of hepatitis B reactivation in patients with autoimmune bu...
https://doi.org/10.1016/j.jaad.2020.12.085
Journal of the American Academy of Dermatology; Li TF, Tang-Lin L et. al.

Jan 18th, 2021 - A retrospective cohort study of hepatitis B reactivation in patients with autoimmune bullous diseases on immunosuppressive therapy in Singapore.|2021|Li TF,Tang-Lin L,Ang CC,|

Incidence of pemphigoid diseases in Northern Germany in 2016 - first data from the Schl...
https://doi.org/10.1111/jdv.17107
Journal of the European Academy of Dermatology and Venere... van Beek N, Weidinger A et. al.

Jan 11th, 2021 - Autoimmune bullous diseases (AIBD) are rare disorders characterized by autoantibody formation against components of adhesion molecules; in pemphigoid diseases (PD), these are proteins of hemidesmosomes and basement membrane, important for cell-mat...

Characteristics and outcomes of COVID-19 in patients with autoimmune bullous diseases: ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836213
Journal of the American Academy of Dermatology; Mahmoudi H, Farid AS et. al.

Dec 28th, 2020 - Characteristics and outcomes of COVID-19 in patients with autoimmune bullous diseases: A retrospective cohort study.|2020|Mahmoudi H,Farid AS,Nili A,Dayani D,Tavakolpour S,|

see more →

News  3 results

Pemphigus Foliaceus: A Case Report and Short Review
https://www.mdedge.com/dermatology/article/67396/contact-dermatitis/pemphigus-foliaceus-case-report-and-short-review
Khachemoune A, Guldbakke KK et. al.

Pemphigus describes a group of autoimmune chronic bullous diseases, originally named in 1791. 1 The term pemphigus stems from the Greek pemphix meaning blister or bubble.

Aggressive Refractory Pemphigus Vulgaris That Responded to Plasmapheresis
https://www.medscape.com/viewarticle/935102_2

Background Pemphigus vulgaris (PV) encompasses a group of life-threatening autoimmune bullous diseases characterized by flaccid blisters and erosions of the mucous membrane and skin. The average age of onset is between 50 and 70 years. PV rarely o...

Treating Immunobullous Diseases: An Update
https://www.medscape.com/viewarticle/470164

Autoimmune bullous diseases are often associated with significant morbidity and some can even cause mortality, if left untreated. Multiple therapies are now available to treat these blistering conditions. However, few have been evaluated objective...

see more →